Novartis Begins Construction on Biomedical Research Facility in San Diego

Novartis has begun construction on a new global biomedical research facility in San Diego, California. The center is designed to enhance the company’s drug discovery capabilities and further its efforts in advancing medical research. This development marks a significant step for Novartis in expanding its presence in the United States and strengthening its focus on innovative healthcare solutions.

The facility will serve as a hub for biomedical research, with the goal of accelerating advancements in drug development. San Diego was selected as the location due to its reputation as a leading biotechnology and life sciences hub, offering access to top-tier talent and collaboration opportunities within the scientific community. The project underscores Novartis’ commitment to investing in cutting-edge research infrastructure to support its mission of addressing unmet medical needs globally.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: February 9, 2026

Author

GOAI